Overview on current approach on recurrent miscarriage and threatened miscarriage
Open Access
- 30 November 2020
- journal article
- Published by Heighten Science Publications Corporation in Clinical Journal of Obstetrics and Gynecology
- Vol. 3 (2), 151-157
- https://doi.org/10.29328/journal.cjog.1001070
Abstract
Miscarriage is a frequent outcome of pregnancy, with major emotional implications to the couple experiencing such an event. Threatened miscarriage is the commonest complication of early pregnancy and affects about 20% of pregnancies. It presents with vaginal bleeding with or without abdominal cramps. On the other hand recurrent miscarriages are post implantation failures in natural conception. Increasing age of women, smoking, obesity or polycystic ovary syndrome (PCOS) and a previous history of miscarriage are risk factors for threatened miscarriage. The pathophysiology has been associated with changes in levels of cytokines or maternal immune dysfunction. Clinical history and examination, maternal serum biochemistry and ultrasound findings are important to determine the treatment options and provide valuable information for the prognosis. Many surgical and non-surgical interventions are used in the management of threatened and recurrent miscarriages. In this review, we present available evidence-based guidance on the incidence, pathophysiology, investigation and clinical management of recurrent miscarriage and threatened miscarriage, focusing mainly on the first trimester of pregnancy and primary healthcare settings. The review is structured to be clinically relevant. We have critically appraised the evidence to produce a concise answer for clinical practice.Keywords
This publication has 24 references indexed in Scilit:
- Human chorionic gonadotrophin for threatened miscarriageEmergencias, 2010
- Diagnostic factors identified in 1020 women with two versus three or more recurrent pregnancy lossesFertility and Sterility, 2010
- Treatment options for threatened miscarriageMaturitas, 2009
- The detection of anti-β2-glycoprotein I antibodies is associated with increased risk of pregnancy loss in women with threatened abortion in the first trimesterEuropean Journal of Obstetrics & Gynecology and Reproductive Biology, 2007
- Effects of enoxaparin on late pregnancy complications and neonatal outcome in women with recurrent pregnancy loss and thrombophilia: results from the Live-Enox studyFertility and Sterility, 2005
- Recurrent miscarriageBMJ Sexual & Reproductive Health, 2005
- The pathogenesis of infertility and early pregnancy loss in polycystic ovary syndromeBest Practice & Research Clinical Obstetrics & Gynaecology, 2004
- Threatened miscarriage: evaluation and managementBMJ, 2004
- Progestogen for preventing miscarriagePublished by Wiley ,2003
- Maternal age and fetal loss: population based register linkage studyBMJ, 2000